{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:50:47Z","timestamp":1791355847385,"version":"4.3.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T00:00:00Z","timestamp":1403136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T00:00:00Z","timestamp":1403136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/leu.2014.198","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T06:38:54Z","timestamp":1403159934000},"page":"337-345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events"],"prefix":"10.1038","volume":"29","author":[{"given":"D","family":"Rizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Chauzeix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Trimoreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J B","family":"Woillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Genevieve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Labrousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Dmytruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Remenieras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Feuillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Gachard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,19]]},"reference":[{"key":"BFleu2014198_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.blre.2010.03.004","volume":"24","author":"T Butler","year":"2010","unstructured":"Butler T, Gribben JG . Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia. Blood Rev 2010; 24: 135\u2013141.","journal-title":"Blood Rev"},{"key":"BFleu2014198_CR2","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.3109\/10428194.2013.783913","volume":"54","author":"R Rosenquist","year":"2013","unstructured":"Rosenquist R, Cortese D, Bhoi S, Mansouri L, Gunnarsson R . Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand? Leuk Lymphoma 2013; 54: 2351\u20132364.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2014198_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.blre.2008.05.003","volume":"23","author":"F Van Bockstaele","year":"2009","unstructured":"Van Bockstaele F, Verhasselt B, Philipp\u00e9 J . Prognostic markers in chronic lymphocytic leukemia: a comprehensive review. Blood Rev 2009; 23: 25\u201347.","journal-title":"Blood Rev"},{"key":"BFleu2014198_CR4","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20110921","volume":"208","author":"G Fabbri","year":"2011","unstructured":"Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011; 208: 1389\u20131401.","journal-title":"J Exp Med"},{"key":"BFleu2014198_CR5","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","volume":"118","author":"D Rossi","year":"2011","unstructured":"Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011; 118: 6904\u20136908.","journal-title":"Blood"},{"key":"BFleu2014198_CR6","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1182\/blood-2011-12-395673","volume":"119","author":"D Rossi","year":"2012","unstructured":"Rossi D, Fangazio M, Rasi S, Vaisitti T, Monti S, Cresta S et al. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. Blood 2012; 119: 2854\u20132862.","journal-title":"Blood"},{"key":"BFleu2014198_CR7","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","volume":"121","author":"D Rossi","year":"2013","unstructured":"Rossi D, Rasi S, Spina V, Bruscaggin A, Monti S, Ciardullo C et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood 2013; 121: 1403\u20131412.","journal-title":"Blood"},{"key":"BFleu2014198_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/leu.2013.263","volume":"28","author":"S Jeromin","year":"2013","unstructured":"Jeromin S, Weissmann S, Haferlach C, Dicker F, Bayer K, Grossmann V et al. SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients. Leukemia 2013; 28: 108\u2013117.","journal-title":"Leukemia"},{"key":"BFleu2014198_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","volume":"152","author":"DA Landau","year":"2013","unstructured":"Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013; 152: 714\u2013726.","journal-title":"Cell"},{"issue":"Suppl 1","key":"BFleu2014198_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/hon.2071","volume":"31","author":"SP Treon","year":"2013","unstructured":"Treon SP . XIII. Waldenstr\u00f6m\u2019s macroglobulinaemia: an indolent B-cell lymphoma with distinct molecular and clinical features. Hematol Oncol 2013; 31 (Suppl 1): 76\u201380.","journal-title":"Hematol Oncol"},{"key":"BFleu2014198_CR11","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1002\/cncr.26627","volume":"118","author":"H Wang","year":"2012","unstructured":"Wang H, Chen Y, Li F, Delasalle K, Wang J, Alexanian R et al. Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study. Cancer 2012; 118: 3793\u20133800.","journal-title":"Cancer"},{"key":"BFleu2014198_CR12","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1182\/blood-2013-04-494849","volume":"121","author":"SP Treon","year":"2013","unstructured":"Treon SP, Hunter ZR . A new era for Waldenstrom macroglobulinemia: MYD88 L265P. Blood 2013; 121: 4434\u20134436.","journal-title":"Blood"},{"key":"BFleu2014198_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/leu.2012.257","volume":"27","author":"N Gachard","year":"2013","unstructured":"Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D et al. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphomas. Leukemia 2013; 27: 183\u2013189.","journal-title":"Leukemia"},{"key":"BFleu2014198_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3816\/CLM.2005.n.006","volume":"5","author":"GA Pangalis","year":"2005","unstructured":"Pangalis GA, Kyrtsonis M-C, Kontopidou FN, Siakantaris MP, Dimopoulou MN, Vassilakopoulos TP et al. Differential diagnosis of Waldenstrom\u2019s macroglobulinemia and other B-cell disorders. Clin Lymphoma 2005; 5: 235\u2013240.","journal-title":"Clin Lymphoma"},{"issue":"Suppl 1","key":"BFleu2014198_CR15","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1002\/cyto.b.20550","volume":"78","author":"ML McMaster","year":"2010","unstructured":"McMaster ML, Landgren O . Prevalence, clinical aspects, and natural history of IgM MGUS. Cytometry B Clin Cytom 2010; 78 (Suppl 1): S91\u2013S97.","journal-title":"Cytometry B Clin Cytom"},{"key":"BFleu2014198_CR16","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1182\/blood-2003-03-0801","volume":"102","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003; 102: 3759\u20133764.","journal-title":"Blood"},{"key":"BFleu2014198_CR17","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/blood-2006-02-005488","volume":"108","author":"WJ Chng","year":"2006","unstructured":"Chng WJ, Schop RF, Price-Troska T, Ghobrial I, Kay N, Jelinek DF et al. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood 2006; 108: 2755\u20132763.","journal-title":"Blood"},{"key":"BFleu2014198_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.leu.2404520","volume":"21","author":"NC Guti\u00e9rrez","year":"2007","unstructured":"Guti\u00e9rrez NC, Ocio EM, de Las Rivas J, Maiso P, Delgado M, Fermi\u00f1\u00e1n E et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenstr\u00f6m\u2019s macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia 2007; 21: 541\u2013549.","journal-title":"Leukemia"},{"key":"BFleu2014198_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1158\/1078-0432.CCR-13-1993","volume":"20","author":"A Vardi","year":"2014","unstructured":"Vardi A, Agathangelidis A, Sutton L-A, Chatzouli M, Scarf\u00f2 L, Mansouri L et al. IgG-Switched CLL has a distinct immunogenetic signature from the common MD Variant: ontogenetic implications. Clin Cancer Res Off J Am Assoc Cancer Res 2014; 20: 323\u2013330.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"BFleu2014198_CR20","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.leukres.2010.12.005","volume":"35","author":"W Xu","year":"2011","unstructured":"Xu W, Wang Y-H, Fan L, Fang C, Zhu D-X, Wang D-M et al. Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia. Leuk Res 2011; 35: 1060\u20131065.","journal-title":"Leuk Res"},{"key":"BFleu2014198_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-2141.1990.tb06367.x","volume":"76","author":"DG Oscier","year":"1990","unstructured":"Oscier DG, Stevens J, Hamblin TJ, Pickering RM, Lambert R, Fitchett M . Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukaemia. Br J Haematol 1990; 76: 352\u2013358.","journal-title":"Br J Haematol"},{"key":"BFleu2014198_CR22","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM Van Dongen","year":"2003","unstructured":"Van Dongen JJM, Langerak AW, Br\u00fcggemann M, Evans PAS, Hummel M, Lavender FL et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257\u20132317.","journal-title":"Leukemia"},{"key":"BFleu2014198_CR23","doi-asserted-by":"publisher","first-page":"10209","DOI":"10.1073\/pnas.180316097","volume":"97","author":"IS Lossos","year":"2000","unstructured":"Lossos IS, Alizadeh AA, Eisen MB, Chan WC, Brown PO, Botstein D et al. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci USA 2000; 97: 10209\u201310213.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014198_CR24","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A, Leupolt E, Kr\u00f6ber A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910\u20131916.","journal-title":"N Engl J Med"},{"key":"BFleu2014198_CR25","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/sj.leu.2404727","volume":"21","author":"C Bastard","year":"2007","unstructured":"Bastard C, Raux G, Fruchart C, Parmentier F, Vaur D, Penther D et al. Comparison of a quantitative PCR method with FISH for the assessment of the four aneuploidies commonly evaluated in CLL patients. Leukemia 2007; 21: 1460\u20131463.","journal-title":"Leukemia"},{"key":"BFleu2014198_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ajh.23494","volume":"88","author":"D Rizzo","year":"2013","unstructured":"Rizzo D, Lotay A, Gachard N, Marfak I, Faucher J-L, Trimoreau F et al. Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival. Am J Hematol 2013; 88: 747\u2013753.","journal-title":"Am J Hematol"},{"key":"BFleu2014198_CR27","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood.V78.8.1901.1901","volume":"78","author":"G Dighiero","year":"1991","unstructured":"Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet JL . B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL. Blood 1991; 78: 1901\u20131914.","journal-title":"Blood"},{"key":"BFleu2014198_CR28","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848\u20131854.","journal-title":"Blood"},{"key":"BFleu2014198_CR29","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840\u20131847.","journal-title":"Blood"},{"key":"BFleu2014198_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3324\/haematol.11622","volume":"93","author":"N Gachard","year":"2008","unstructured":"Gachard N, Salviat A, Boutet C, Arnoulet C, Durrieu F, Lenormand B et al. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method. Haematologica 2008; 93: 215\u2013223.","journal-title":"Haematologica"},{"key":"BFleu2014198_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.leukres.2006.07.006","volume":"31","author":"A Victor Hoffbrand","year":"2007","unstructured":"Victor Hoffbrand A, Hamblin TJ . Is \u00ab leukemia \u00bb an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia? Leuk Res 2007; 31: 273\u2013275.","journal-title":"Leuk Res"},{"key":"BFleu2014198_CR32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3324\/haematol.2010.028779","volume":"96","author":"I Del Giudice","year":"2011","unstructured":"Del Giudice I, Mauro FR, De Propris MS, Santangelo S, Marinelli M, Peragine N et al. White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia. Haematologica 2011; 96: 626\u2013630.","journal-title":"Haematologica"},{"key":"BFleu2014198_CR33","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","volume":"119","author":"A Agathangelidis","year":"2012","unstructured":"Agathangelidis A, Darzentas N, Hadzidimitriou A, Brochet X, Murray F, Yan X-J et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 2012; 119: 4467\u20134475.","journal-title":"Blood"},{"key":"BFleu2014198_CR34","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1038\/leu.2013.98","volume":"27","author":"JC Strefford","year":"2013","unstructured":"Strefford JC, Sutton L-A, Baliakas P, Agathangelidis A, Mal\u010d\u00edkov\u00e1 J, Plevova K et al. Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia 2013; 27: 2196\u20132199.","journal-title":"Leukemia"},{"key":"BFleu2014198_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1309\/2A0FL1HM5PN2510P","volume":"123","author":"P Lin","year":"2005","unstructured":"Lin P, Hao S, Handy BC, Bueso-Ramos CE, Medeiros LJ . Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients. Am J Clin Pathol 2005; 123: 200\u2013205.","journal-title":"Am J Clin Pathol"},{"key":"BFleu2014198_CR36","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","volume":"121","author":"L Xu","year":"2013","unstructured":"Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X et al. MYD88 L265P in Waldenstr\u00f6m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood 2013; 121: 2051\u20132058.","journal-title":"Blood"},{"key":"BFleu2014198_CR37","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/leu.2013.62","volume":"27","author":"C Jim\u00e9nez","year":"2013","unstructured":"Jim\u00e9nez C, Sebasti\u00e1n E, Chill\u00f3n MC, Giraldo P, Mariano Hern\u00e1ndez J, Escalante F et al. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstr\u00f6m\u2019s macroglobulinemia. Leukemia 2013; 27: 1722\u20131728.","journal-title":"Leukemia"},{"key":"BFleu2014198_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2141.2008.07456.x","volume":"144","author":"G Pratt","year":"2009","unstructured":"Pratt G, Harding S, Holder R, Fegan C, Pepper C, Oscier D et al. Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia. Br J Haematol 2009; 144: 217\u2013222.","journal-title":"Br J Haematol"},{"key":"BFleu2014198_CR39","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1111\/j.1349-7006.2009.01341.x","volume":"100","author":"M Hojjat-Farsangi","year":"2009","unstructured":"Hojjat-Farsangi M, Jeddi-Tehrani M, Razavi SM, Sharifian RA, Mellstedt H, Shokri F et al. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia. Cancer Sci 2009; 100: 2346\u20132353.","journal-title":"Cancer Sci"},{"key":"BFleu2014198_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2141.2008.07166.x","volume":"142","author":"D Rossi","year":"2008","unstructured":"Rossi D, Cerri M, Capello D, Deambrogi C, Rossi FM, Zucchetto A et al. Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol 2008; 142: 202\u2013215.","journal-title":"Br J Haematol"},{"key":"BFleu2014198_CR41","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2013-02-486209","volume":"121","author":"D Rossi","year":"2013","unstructured":"Rossi D, Spina V, Bomben R, Rasi S, Dal-Bo M, Bruscaggin A et al. Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. Blood 2013; 121: 4902\u20134905.","journal-title":"Blood"},{"key":"BFleu2014198_CR42","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3324\/haematol.2010.025437","volume":"95","author":"S Zibellini","year":"2010","unstructured":"Zibellini S, Capello D, Forconi F, Marcatili P, Rossi D, Rattotti S et al. Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. Haematologica 2010; 95: 1792\u20131796.","journal-title":"Haematologica"},{"key":"BFleu2014198_CR43","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1182\/blood-2011-03-341651","volume":"118","author":"AA Warsame","year":"2011","unstructured":"Warsame AA, Aasheim H-C, Nustad K, Tr\u00f8en G, Tierens A, Wang V et al. Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity. Blood 2011; 118: 3331\u20133339.","journal-title":"Blood"},{"key":"BFleu2014198_CR44","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/leu.2012.3","volume":"26","author":"V Bikos","year":"2012","unstructured":"Bikos V, Darzentas N, Hadzidimitriou A, Davis Z, Hockley S, Traverse-Glehen A et al. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. Leukemia 2012; 26: 1638\u20131646.","journal-title":"Leukemia"},{"key":"BFleu2014198_CR45","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/leu.2013.333","volume":"28","author":"D Cortese","year":"2013","unstructured":"Cortese D, Sutton L-A, Cahill N, Smedby KE, Geisler C, Gunnarsson R et al. On the way towards a \u00ab CLL prognostic index \u00bb: focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort. Leukemia 2013; 28: 710\u2013713.","journal-title":"Leukemia"},{"key":"BFleu2014198_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente XS, Pinyol M, Quesada V, Conde L, Ord\u00f3\u00f1ez GR, Villamor N et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101\u2013105.","journal-title":"Nature"},{"key":"BFleu2014198_CR47","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2141.2009.07816.x","volume":"146","author":"M Di Ianni","year":"2009","unstructured":"Di Ianni M, Baldoni S, Rosati E, Ciurnelli R, Cavalli L, Martelli MF et al. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. Br J Haematol 2009; 146: 689\u2013691.","journal-title":"Br J Haematol"},{"key":"BFleu2014198_CR48","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2141.2010.08368.x","volume":"151","author":"P Sportoletti","year":"2010","unstructured":"Sportoletti P, Baldoni S, Cavalli L, Del Papa B, Bonifacio E, Ciurnelli R et al. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. Br J Haematol 2010; 151: 404\u2013406.","journal-title":"Br J Haematol"},{"key":"BFleu2014198_CR49","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","volume":"365","author":"L Wang","year":"2011","unstructured":"Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011; 365: 2497\u20132506.","journal-title":"N Engl J Med"},{"key":"BFleu2014198_CR50","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/leu.2012.357","volume":"27","author":"N Villamor","year":"2013","unstructured":"Villamor N, Conde L, Mart\u00ednez-Trillos A, Cazorla M, Navarro A, Be\u00e0 S et al. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia 2013; 27: 1100\u20131106.","journal-title":"Leukemia"},{"key":"BFleu2014198_CR51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1182\/blood-2011-10-386144","volume":"119","author":"V Balatti","year":"2012","unstructured":"Balatti V, Bottoni A, Palamarchuk A, Alder H, Rassenti LZ, Kipps TJ et al. NOTCH1 mutations in CLL associated with trisomy 12. Blood 2012; 119: 329\u2013331.","journal-title":"Blood"},{"key":"BFleu2014198_CR52","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1182\/blood-2011-04-349134","volume":"118","author":"MJ Maurer","year":"2011","unstructured":"Maurer MJ, Cerhan JR, Katzmann JA, Link BK, Allmer C, Zent CS et al. Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia. Blood 2011; 118: 2821\u20132826.","journal-title":"Blood"},{"key":"BFleu2014198_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2141.1987.tb06885.x","volume":"66","author":"TJ Hamblin","year":"1987","unstructured":"Hamblin TJ, Oscier DG, Stevens JR, Smith JL . Long survival in B-CLL correlates with surface IgM kappa phenotype. Br J Haematol 1987; 66: 21\u201326.","journal-title":"Br J Haematol"},{"key":"BFleu2014198_CR54","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1309\/FDGWB5C2MYRYXH2E","volume":"123","author":"CC Yin","year":"2005","unstructured":"Yin CC, Lin P, Carney DA, Handy BC, Rassidakis GZ, Admirand JH et al. Chronic lymphocytic leukemia\/small lymphocytic lymphoma associated with IgM paraprotein. Am J Clin Pathol 2005; 123: 594\u2013602.","journal-title":"Am J Clin Pathol"},{"key":"BFleu2014198_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/ejh.12290","volume":"93","author":"L Shvidel","year":"2014","unstructured":"Shvidel L, Tadmor T, Braester A, Bairey O, Rahimi-Levene N, Herishanu Y et al. Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group. Eur J Haematol 2014; 93: 29\u201333.","journal-title":"Eur J Haematol"},{"key":"BFleu2014198_CR56","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/1097-0142(19880115)61:2<279::AID-CNCR2820610215>3.0.CO;2-4","volume":"61","author":"C Rozman","year":"1988","unstructured":"Rozman C, Montserrat E, Vi\u00f1olas N . Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance. Cancer 1988; 61: 279\u2013283.","journal-title":"Cancer"},{"key":"BFleu2014198_CR57","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1182\/blood-2010-06-288274","volume":"116","author":"R Letestu","year":"2010","unstructured":"Letestu R, L\u00e9vy V, Eclache V, Baran-Marszak F, Vaur D, Naguib D et al. Prognosis of Binet stage A chronic lymphocytic leukemia patients: the strength of routine parameters. Blood 2010; 116: 4588\u20134590.","journal-title":"Blood"},{"key":"BFleu2014198_CR58","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.beha.2009.05.006","volume":"22","author":"C Codony","year":"2009","unstructured":"Codony C, Crespo M, Abrisqueta P, Montserrat E, Bosch F . Gene expression profiling in chronic lymphocytic leukaemia. Best Pract Res Clin Haematol 2009; 22: 211\u2013222.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFleu2014198_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/bjh.12344","volume":"162","author":"AD Ramsay","year":"2013","unstructured":"Ramsay AD, Rodriguez-Justo M . Chronic lymphocytic leukaemia\u2014the role of the microenvironment pathogenesis and therapy. Br J Haematol 2013; 162: 15\u201324.","journal-title":"Br J Haematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2014198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014198","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:35:16Z","timestamp":1648744516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2014198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,19]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFleu2014198"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.198","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,19]]},"assertion":[{"value":"28 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}